This is a StreetInsider.com Premium Only Page

Edwards Lifesciences (EW) – Press Releases

Apr 18, 2024 07:10 AM Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024

Apr 7, 2024 04:30 PM Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It

Mar 19, 2024 07:05 AM PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis

Mar 11, 2024 02:00 PM Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR

Feb 23, 2024 07:05 AM Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference

Feb 6, 2024 04:15 PM Edwards Lifesciences Reports Fourth Quarter Results

Feb 2, 2024 07:00 AM Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Jan 30, 2024 07:05 AM Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024

Jan 2, 2024 09:00 AM Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023 08:30 AM Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Oct 26, 2023 03:06 PM CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION

Oct 26, 2023 02:00 PM TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION

Oct 25, 2023 04:15 PM EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Oct 24, 2023 02:00 PM FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE

Oct 19, 2023 08:30 AM EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK

Oct 18, 2023 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023

Aug 28, 2023 08:10 AM EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE

Jul 26, 2023 04:15 PM EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

Jul 19, 2023 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023

May 17, 2023 04:30 AM DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY

May 7, 2023 08:00 PM EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA

Apr 26, 2023 04:15 PM EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Apr 19, 2023 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2023

Mar 6, 2023 09:00 AM EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS

Jan 31, 2023 04:15 PM EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

Jan 24, 2023 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023

Jan 5, 2023 09:05 AM EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Dec 8, 2022 08:01 AM EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

Dec 8, 2022 08:00 AM EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN

Nov 27, 2022 10:25 AM EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

Nov 10, 2022 01:00 AM JCB and East West Banking Corporation announce the launch of EastWest JCB Credit Card

Nov 1, 2022 09:00 AM EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE

Oct 27, 2022 04:15 PM EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

Oct 20, 2022 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022

Sep 17, 2022 11:30 AM EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

Sep 15, 2022 09:00 AM EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

Sep 12, 2022 09:05 AM EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

Aug 17, 2022 08:30 AM EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

Jul 28, 2022 04:15 PM EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

Jul 21, 2022 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 28, 2022

May 23, 2022 08:10 AM EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

May 16, 2022 09:15 AM EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022

Apr 26, 2022 04:15 PM EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Apr 19, 2022 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022

Jan 26, 2022 04:15 PM EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

Jan 19, 2022 07:05 AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022

Jan 5, 2022 08:10 AM EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Dec 20, 2021 09:05 AM EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENT

Dec 8, 2021 09:05 AM Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Nov 6, 2021 01:47 PM Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program